(2R,3R)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol → Bupropion Morpholinol (2R,3R)-Isomer

HRID 650505

반응식

HRID 650505 반응식
[Cl:1][C:2]1[CH:3]=[C:4]([C@@:8]2([OH:17])[O:13][CH2:12][C:11]([CH3:15])([CH3:14])[NH:10][C@@H:9]2[CH3:16])[CH:5]=[CH:6][CH:7]=1>C(OCC)C>[ClH:1].[Cl:1][C:2]1[CH:3]=[C:4]([C@@:8]2([OH:17])[O:13][CH2:12][C:11]([CH3:14])([CH3:15])[NH:10][C@@H:9]2[CH3:16])[CH:5]=[CH:6][CH:7]=1

참가 물질

3

반응물 1

HCID 9943908(2R,3R)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol

생성물 1

HCID 9943907Bupropion Morpholinol (2R,3R)-Isomer수율 90%

시약·촉매·용매 1

HCID 3283Diethyl Ether용매

실험 절차

Hydrochloride salts of the separated enantiomers were obtained by the following processes. 1.25 g (0.005 mol) of optical isomer 1 (retention time 6.117 min) ((−)-(2R,3R)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol) was dissolved in diethyl ether. The solution was filtered and the filtrate was chilled in an ice-bath adding ethereal hydrogen chloride until the solution was acidic. After standing at ambient temperature for 24h, the resulting solid was filtered, washed with diethyl ether and dried in a vacuum oven at 60° C. for 18h to give 1.32 g (90%) of (−)-(2R,3R)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol hydrochloride as a white solid: mp 208-209° C. NMR (300 Mhz, DMSO-d6); δ 9.72 (br, 1H), 8.76 (br, 1H), 7.54-7.41 (m, 5H) 3.98 (d, 1H), 3.52 (d, 1H), 3.37 (br s, 1H), 1.53 (s, 3H), 1.29 (s, 3H), 0.97 (d, 3H). Anal. Calcd for C,13H19Cl2NO2: C, 53.43; H, 6.55; N, 4.79. Found: C, 53.35; H, 6.57; N, 4.71.

후처리

  1. filtrationThe solution was filtered
  2. temperaturethe filtrate was chilled in an ice-bath
  3. additionadding ethereal hydrogen chloride until the solution
  4. customAfter standing at ambient temperature for 24h
  5. filtrationthe resulting solid was filtered
  6. washwashed with diethyl ether
  7. dry with materialdried in a vacuum oven at 60° C. for 18h

출처 및 근거

ORD 기록
ord-c7b84045abc749f98841b8dc5690e4de
출처 데이터셋
uspto-grants-2001_08
특허 번호
US06274579B1

연결된 노트

불러오는 중…